📚 Stock Market Glossary

Clear, beginner-friendly explanations, real-world analogies, and visual formulas for key stock market terminology.

View Mode:

Total 649 terms available

Prime Editing Search-and-Replace Platform

Corporate & Tech

💡 Key Takeaway: A next-generation search-and-replace gene editing technology that writes new genetic information into specified DNA sites without double-strand breaks.

Word Processor Search-and-Replace Analogy: While first-gen CRISPR scissors tore the paper sheet to fix a typo (risking unintended collateral damage), Prime Editing works like typing Ctrl+F to find the error and Ctrl+H to cleanly overwrite the exact sequence.

😎 10-Second Show-off Pro Tip for Friends!

☕ Show-off Tip: 'First-gen CRISPR scissors are giving way to Prime Editing. By acting as a search-and-replace word processor without cutting double-stranded DNA, it can theoretically correct nearly 89% of known genetic diseases.'

📖 Beginner-Friendly Explanation

STEP 1

Core Concept & Meaning

Prime Editing is a cutting-edge genomic search-and-replace platform developed in 2019 by Dr. David Liu's laboratory at the Broad Institute of MIT and Harvard.

Unlike classic CRISPR-Cas9, which cuts both DNA strands like molecular scissors (triggering unintended insertions or deletions), Prime Editing utilizes an engineered reverse transcriptase fused to a nickase Cas9 and a prime editing guide RNA (pegRNA) to write new genetic sequences directly into targeted sites.

STEP 2

Why It Matters & Mechanism

No Double-Strand Breaks (DSBs): Eliminates chromosome rearrangements and cytotoxic off-target damage.
Universal Editing Scope: Capable of correcting insertions, deletions, and all 12 possible base-to-base transitions and transversions, addressing up to 89% of known pathogenic human genetic mutations.
Integrated pegRNA: Simultaneously specifies the target genomic locus and encodes the precise replacement sequence.

STEP 3

Practical Investment Tips & Pitfalls

Track pioneering gene therapy biotechs owning foundational Prime Editing IP and advancing clinical assets for sickle cell disease, liver metabolic disorders, and retinal dystrophies. Commercial success heavily depends on in vivo delivery vectors such as engineered lipid nanoparticles (LNPs).

📊 Prime Editing Complex Architecture

Prime Editor Complex = Cas9 Nickase(H840A) + Reverse Transcriptase + pegRNA

▶ pegRNA specifies target locus and template sequence, directing reverse transcriptase to synthesize corrected genetic information without DSBs.

⚖️ Key Comparison at a Glance

Feature	Prime Editing (3rd Gen)	Base Editing (2nd Gen)	Standard CRISPR-Cas9 (1st Gen)
DNA Cutting Mechanism	Single-strand nick only (No DSBs)	Single-strand nick only (No DSBs)	Double-strand breaks (DSBs triggered)
Editing Scope	All 12 base swaps + targeted insertions/deletions	Restricted transition mutations (C to T, A to G)	Primarily gene knockouts via random repair
Off-Target Risk	Extremely low (High precision)	Low	Higher risk of unintended indels and translocations
Underlying Engine	Search-and-replace reverse transcription	Enzymatic chemical base deamination	Relies on error-prone non-homologous end joining (NHEJ)

⚔️ Don't Mix These Up! (Head-to-Head Comparison)

VSMonoclonal Antibody (mAb)

View Monoclonal→

💡 Crucial Difference: Monoclonal antibodies bind extracellular protein targets, while Prime Editing permanently rewrites the underlying DNA code inside the cell nucleus.

📌 Practical Market & Real-World Example

Preclinical studies demonstrate Prime Editing correcting pathogenic gene deletions in hemophilia and sickle cell models without chromosomal rearrangements, opening new frontiers in precision genetic medicine.